CLINICAL_TRIALS
trial_result
· 2016-12-26
Clinical Trial Update: Enteroaggregative E.Coli (EAEC) [Phase 1]
Summary
A Phase 1 clinical trial for Enteroaggregative Escherichia coli infection sponsored by NIAID was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Escherichia Coli Infections | Phase 1 | Status: TERMINATED